0001231919-26-001529.txt : 20261103 0001231919-26-001529.hdr.sgml : 20261103 20261103152644 ACCESSION NUMBER: 0001231919-26-001529 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261103 DATE AS OF CHANGE: 20261103 EFFECTIVENESS DATE: 20261103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rgenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001801266 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-603441 FILM NUMBER: 261516966 BUSINESS ADDRESS: STREET 1: 15 LINCOLN ROAD CITY: BROOKLINE STATE: MA ZIP: 02445 BUSINESS PHONE: 781-608-3996 MAIL ADDRESS: STREET 1: 15 LINCOLN ROAD CITY: BROOKLINE STATE: MA ZIP: 02445 D 1 primary_doc.xml X0708 D LIVE 0001801266 Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 781-608-3996 DELAWARE None None Corporation true Hualin Simon Xi c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Executive Officer Director Yichao Fan c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Debasish Roychowdhury c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Julia Kaufman c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Sean Zhang c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Promoter Cillian King c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Promoter James Kasuboski c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Travis Wager c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Executive Officer Weng Zhiping c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Director Jeff Guckert c/o Rgenta Therapeutics, Inc. 300 TradeCenter, Suite 6600 Woburn MA MASSACHUSETTS 01801 Executive Officer Other Technology Decline to Disclose 06b false 2026-10-19 false true true false 0 130107279 41852307 88254972 Series B-1 Preferred Stock, Series B-2 Preferred Stock and Non-Voting Special Preferred Stock, including shares issued upon conversion of outstanding convertible securities and the common stock issuable upon conversion of such preferred stock. false 9 0 0 0 false Rgenta Therapeutics, Inc. Hualin S. Xi Hualin S. Xi Chief Executive Officer 2026-11-03